Delanzomib is an orally active proteasome inhibitor. Delanzomib has been shown to down-modulate NF-kappaB, induce apoptosis, inhibit angiogenesis and M-CSF-RANKL-induced osteoclastogenesis.
Molecular Weight:
413.28
CAS Number:
[847499-27-8]
* VAT and and shipping costs not included. Errors and price changes excepted
